Definitely yes to 2mg x 2 week dose given reduced dose request was based on an anomaly from historic study on a rat BUT no to removing adrenal monitoring despite follow-up studies that confirmed it wasn't linked to PPS.
FDA burnt too many times and given OA TAM potential they want to show extreme prudence.
Not a major deal rather impacts on patient convenience (takes extra time), their comfort and our cost.
2x2 Yay Or Nay From The FDA?, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.5¢ | $112.3K | 450.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 322039 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 46325 | 3 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |